The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells

The receptor for the urokinase-type plasminogen activator (uPAR) is a widely recognized master regulator of cell migration and uPAR(88–92) is the minimal sequence required to induce cell motility and angiogenesis by interacting with the formyl peptide receptor type 1 (FPR1). In this study, we presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingangi, Vincenzo, Bifulco, Katia, Yousif, Ali Munaim, Ragone, Concetta, Motti, Maria Letizia, Rea, Domenica, Minopoli, Michele, Botti, Giovanni, Scognamiglio, Giuseppe, Fazioli, Flavio, Gallo, Michele, De Chiara, Annarosaria, Arra, Claudio, Grieco, Paolo, Carriero, Maria Vincenza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342356/
https://www.ncbi.nlm.nih.gov/pubmed/27323409
http://dx.doi.org/10.18632/oncotarget.9976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342356/
https://www.ncbi.nlm.nih.gov/pubmed/27323409
http://dx.doi.org/10.18632/oncotarget.9976

Ejemplares similares